You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 36 No. 6, June 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reversible Hepatic Dysfunction Owing to Guanidine Treatment

Erich W. Streib, MD
Department of Neurology The University of Nebraska Medical Center 42nd and Dewey avenues Omaha, NE 68105

Arch Neurol. 1979;36(6):386.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Guanidine hydrochloride is of value in the treatment of the Lambert-Eaton syndrome1 and botulism.2 More recently, it was tried in the treatment of motor neuron disease.3

Untoward side effects are frequent and include the following: cholinergic reactions of the gastrointestional (GI) system, paresthesias, skin changes, petechiae, and, with high doses, nervousness, tremors, and ataxia1,3,4 More serious are the occasional occurrences of bone marrow depression and aplastic anemia3,4 and probably long-term renal impairment.5,6 Lambert and Howard4 and Henriksson et al6 mention one patient with elevation of alkaline phosphatase level and other indicators of hepatic dysfunction, which reverted to a normal level after discontinuation of treatment with the drug. Norris et al3 have treated more than 200 patients with various doses of guanidine. Liver function abnormalities are not mentioned in their study. We describe a patient with the Lambert-Eaton syndrome . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.